IAD Index of Academic Documents
  • Home Page
  • About
    • About Izmir Academy Association
    • About IAD Index
    • IAD Team
    • IAD Logos and Links
    • Policies
    • Contact
  • Submit A Journal
  • Submit A Conference
  • Submit Paper/Book
    • Submit a Preprint
    • Submit a Book
  • Contact
  • Osmangazi Tıp Dergisi
  • Volume:38 Issue:1
  • PSÖRİATİK ARTRİT TEDAVİSİ: 2015 GÜNCELLEME / PSORIATIC ARTHRITIS TREATMENT: 2015 UPDATE

PSÖRİATİK ARTRİT TEDAVİSİ: 2015 GÜNCELLEME / PSORIATIC ARTHRITIS TREATMENT: 2015 UPDATE

Authors : Döndü Cansu, Cengiz Korkmaz
Pages : 17-25
Doi:http://dx.doi.org/10.20515/otd.91313
View : 88 | Download : 14
Publication Date : 2016-03-14
Article Type : Other Papers
Abstract :ÖZET : Psöriatik artrit insert ignore into journalissuearticles values(PsA);, romatoloji pratiğinde görülebilecek hemen hemen tüm eklem tutulum tipleriyle gidebilen heterojen kronik, destrüktif bir artropatidir. Yaklaşık her 5 psöriazisli hastanın birinde PsA gelişmektedir. PsA’nın tedavisi eklem tutulum tiplerine göre değişmektedir. Tedavide non-steroid antiinflamatuvar ilaçlar insert ignore into journalissuearticles values(NSAİİ); ve hastalık modifiye edici antiromatizmal ilaçlar insert ignore into journalissuearticles values(DMARD); kullanılmaktadır. Romatoloji pratiğinde PsA için tedavi önerisi sunan 2 kuruluş vardır. Biri Avrupa Romatizma ile Savaş Derneği insert ignore into journalissuearticles values(European League Against Rheumatism= EULAR ); diğeri Psöriazis ve PsA Araştırma ve Değerlendirme Grubudur insert ignore into journalissuearticles values( Group for Research and Assessment of Psoriasis and Psoriatic Arthritis= GRAPPA );. Bu yazıda PsA’nın eklem tutulum tiplerine göre belirlenmiş olan, özellikle yeni dönemdeki biyolojik tedaviler insert ignore into journalissuearticles values(tümor nekrozis faktör alfa inhibitörleri, ustekinumab, sekukinumab, apremilast); başta olmak üzere güncel tedaviler EULAR ve GRAPPA’nın son önerileri doğrultusunda tartışılacaktır.   ANAHTAR SÖZCÜKLER: Psöriatik artrit, tedavi, EULAR, GRAPPA, öneriler PSORIATIC ARTHRITIS TREATMENT: 2015 UPDATE ABSTRACT : Psoriatic arthritis insert ignore into journalissuearticles values(PsA); is a chronic, heterogeneous and destructive arthropathy which all types of joint involvement in rheumatology practice can be seen. PsA develops approximately in 1/5 of patients with psoriasis. Non–steroidal anti-inflammatory drugs insert ignore into journalissuearticles values(NSAID); and disease modifying anti-rheumatic drugs insert ignore into journalissuearticles values(DMARD); are the choice of medicine used for treatment of PsA. There are two organizations that recommends treatment modalities for PsA in rheumatology practice; European League Against Rheumatism: EULAR and Group for Research and Assessment of Psoriasis and Psoriatic Arthritis: GRAPPA. New treatment modalities that are determined by the type of joint involvement, especially biological therapies insert ignore into journalissuearticles values(tumor necrosis factor alpha inhibitors, ustecinumab, secucinumab, apremilast);, will be discussed according to the latest recommendations of EULAR and GRAPPA. KEYWORDS: Psoriatic arthritis, treatment, EULAR, GRAPPA, recommendations  
Keywords : psöriatik artrit, tedavi, EULAR, GRAPPA

ORIGINAL ARTICLE URL

* There may have been changes in the journal, article,conference, book, preprint etc. informations. Therefore, it would be appropriate to follow the information on the official page of the source. The information here is shared for informational purposes. IAD is not responsible for incorrect or missing information.


Index of Academic Documents
İzmir Academy Association
CopyRight © 2023-2026